Related references
Note: Only part of the references are listed.Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective
Erika Kapp et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis
Chao Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles
Hamish S. Sutherland et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Fluoroquinolone derivatives and their anti-tubercular activities
Yi-Lei Fan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds
Mattia Zampieri et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery
Iram Khan Iqbal et al.
PATHOGENS (2018)
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
Diana Machado et al.
ANTIBIOTICS-BASEL (2018)
New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State
Santiago Cano-Muniz et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
Lorenzo Guglielmetti et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure Activity Relationships of Benzo[b]thiophene-2carboxamides as Antimalarial Agents
Marco Pieroni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery
Elisa Azzali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
Dirk Bald et al.
MBIO (2017)
6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
Amy S. T. Tong et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis
Diana Machado et al.
FRONTIERS IN MICROBIOLOGY (2017)
Tuberculosis - drugs in the 2016 development pipeline
Barbara E. Laughon et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units
Peter J. Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Efflux Attenuates the Antibacterial Activity of Q203 in Mycobacterium tuberculosis
Jichan Jang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Bumhee Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Identification and validation of novel drug targets in Mycobacterium tuberculosis
Vinayak Singh et al.
DRUG DISCOVERY TODAY (2017)
Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy
Caroline M. Pule et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
Daniel T. Hoagland et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria
Sofia Santos Costa et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
New and Old Hot Drug Targets in Tuberculosis
Laurent Roberto Chiarelli et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development
Devika Mukherjee et al.
FUTURE MICROBIOLOGY (2016)
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Alimuddin Zumla et al.
LANCET INFECTIOUS DISEASES (2016)
Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
Dirk A. Lamprecht et al.
NATURE COMMUNICATIONS (2016)
Boromycin Kills Mycobacterial Persisters without Detectable Resistance
Wilfried Moreira et al.
FRONTIERS IN MICROBIOLOGY (2016)
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis
Diana Machado et al.
PLOS ONE (2016)
Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
Andreas H. Diacon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis
Vadim Makarov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design
Marco Pieroni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis
Giovanni Sotgiu et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
QTc prolongation and treatment of multidrug-resistant tuberculosis
E. Harausz et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis
Giovanni Piccaro et al.
JOURNAL OF ANTIBIOTICS (2015)
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Norbert Heinrich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Bactericidal mode of action of bedaquiline
Kiel Hards et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy
Marco Pieroni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
WHO's new End TB Strategy
Mukund Uplekar et al.
LANCET (2015)
Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group
Nubia Boechat et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
Guido V. Bloemberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antiinfectives targeting enzymes and the proton motive force
Xinxin Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
Suresh B. Lakshminarayana et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
Shenjie Tang et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
Ruben C. Hartkoorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis
Philippa A. Black et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery
Elizabeth M. Kigondu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c
Kawaljit Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Bradley Croy Doak et al.
CHEMISTRY & BIOLOGY (2014)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
Tuberculosis drug discovery in the post-post-genomic era
Benoit Lechartier et al.
EMBO MOLECULAR MEDICINE (2014)
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents
Marco Pieroni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The ATP synthase inhibitor bedaquiline interferes with small-molecule efflux in Mycobacterium smegmatis
Ping Lu et al.
JOURNAL OF ANTIBIOTICS (2014)
Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
Kristin N. Adams et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
Kai Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and Biological Evaluation of Novel 2-Methoxypyridylamino-Substituted Riminophenazine Derivatives as Antituberculosis Agents
Dongfeng Zhang et al.
MOLECULES (2014)
New leads for resistant tuberculosis
Charlotte Harrison
NATURE REVIEWS DRUG DISCOVERY (2014)
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Veronique Dartois
NATURE REVIEWS MICROBIOLOGY (2014)
Non-Replicating Mycobacterium tuberculosis Elicits a Reduced Infectivity Profile with Corresponding Modifications to the Cell Wall and Extracellular Matrix
Joanna Bacon et al.
PLOS ONE (2014)
Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
Koen Andries et al.
PLOS ONE (2014)
An Acyl-CoA Synthetase in Mycobacterium tuberculosis Involved in Triacylglycerol Accumulation during Dormancy
Jaiyanth Daniel et al.
PLOS ONE (2014)
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
Stephen Patterson et al.
TRENDS IN PARASITOLOGY (2014)
Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
Ashish Kumar Kakkar et al.
TUBERCULOSIS (2014)
Synthesis and synergistic antimycobacterial screening of chlorpromazine and its metabolites
Elizabeth M. Kigondu et al.
MEDCHEMCOMM (2014)
Essentiality of Succinate Dehydrogenase in Mycobacterium smegmatis and Its Role in the Generation of the Membrane Potential Under Hypoxia
Ildiko Pecsi et al.
MBIO (2014)
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
Anil Koul et al.
NATURE COMMUNICATIONS (2014)
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
Shashank Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis
Kristina Shigyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Lukas Wanka et al.
CHEMICAL REVIEWS (2013)
Collapsing the Proton Motive Force to Identify Synergistic Combinations against Staphylococcus aureus
Maya A. Farha et al.
CHEMISTRY & BIOLOGY (2013)
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Vija Skripconoka et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Systematic review of clofazimine for the treatment of drug-resistant tuberculosis
M. Gopal et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Antitubercular pharmacodynamics of phenothiazines
Ashley J. Warman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Preliminary Structure-Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
Oluseye K. Onajole et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Kevin Pethe et al.
NATURE MEDICINE (2013)
Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis
Hyungjin Eoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules
Poochit Nonejuie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Srinivasa P. S. Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
Robert C. Goldman
TUBERCULOSIS (2013)
Indoleamides are active against drug-resistant Mycobacterium tuberculosis
Shichun Lun et al.
NATURE COMMUNICATIONS (2013)
A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
Gregory J. Fox et al.
INFECTIOUS DISEASES AND THERAPY (2013)
MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
Valentina La Rosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
Kapil Tahlan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis
Oriana Tabarrini et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis
Annamaria Lilienkampf et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs
Miguel Viveiros et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Targeting the mycobacterial envelope for tuberculosis drug development
Lorenza Favrot et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
Katherine A. Sacksteder et al.
FUTURE MICROBIOLOGY (2012)
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
Eduardo Abbate et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis
Dongfeng Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E. Grzegorzewicz et al.
NATURE CHEMICAL BIOLOGY (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
Diana Machado et al.
PLOS ONE (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
Gail E. Louw et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Impact of fgd1 and ddn Diversity in Mycobacterium tuberculosis Complex on In Vitro Susceptibility to PA-824
Silke Feuerriegel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Kristin N. Adams et al.
CELL (2011)
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB
Marco Pieroni et al.
CHEMMEDCHEM (2011)
The ins and outs of Mycobacterium tuberculosis drug susceptibility testing
E. C. Boettger
CLINICAL MICROBIOLOGY AND INFECTION (2011)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
The challenge of new drug discovery for tuberculosis
Anil Koul et al.
NATURE (2011)
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
Julian G. Hurdle et al.
NATURE REVIEWS MICROBIOLOGY (2011)
SQ109 analogues as potential antimicrobial candidates
Oluseye K. Onajole et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery
Sean Ekins et al.
TRENDS IN MICROBIOLOGY (2011)
Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis
Luiz Pedro S. de Caryalho et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
E. Huitric et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
Venkata M. Reddy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
NOC Chemistry for Tuberculosis-Further Investigations on the Structure-Activity Relationships of Antitubercular Isoxazole-3-carboxylic Acid Ester Derivatives
Marco Pieroni et al.
CHEMMEDCHEM (2010)
New Lipoglycopeptides A Comparative Review of Dalbavancin, Oritavancin and Telavancin
George G. Zhanel et al.
DRUGS (2010)
Rational Design of 5-Phenyl-3-isoxazolecarboxylic Acid Ethyl Esters as Growth Inhibitors of Mycobacterium tuberculosis. A Potent and Selective Series for Further Drug Development
Annamaria Lilienkampf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-D-ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance
Giulia Manina et al.
MOLECULAR MICROBIOLOGY (2010)
The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
Dick van Soolingen et al.
PLOS ONE (2010)
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
Kevin Pethe et al.
NATURE COMMUNICATIONS (2010)
Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
Anna C. Haagsma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
G. E. Louw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
From Serendipity to Rational Antituberculosis Drug Discovery of Mefloquine-Isoxazole Carboxylic Acid Esters
Jialin Mao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Antibiotics for Emerging Pathogens
Michael A. Fischbach et al.
SCIENCE (2009)
The TB laboratory of the future: macrophagebased selection of XDR-TB therapeutics
Marta Martins et al.
FUTURE MICROBIOLOGY (2008)
Pre-clinical experience with daptomycin
P. M. Hawkey
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis
Liliana Rodrigues et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis
Anil Koul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Generation of a set of simple, interpretable ADMET rules of thumb
M. Paul Gleeson
JOURNAL OF MEDICINAL CHEMISTRY (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
Diarylquinolines target subunit c of mycobacterial ATP synthase
Anil Koul et al.
NATURE CHEMICAL BIOLOGY (2007)
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps
Leonard Amaral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910
Marc R. de Jonge et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Drug therapy of experimental tuberculosis (TB): Improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs
Boris V. Nikonenko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Regulatory interplay between proton motive force, ADP, phosphate, and subunit ε in bacterial ATP synthase
Boris A. Feniouk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Screening for novel antituberculosis agents that are effective against multidrug resistant tuberculosis
Makoto Matsumoto et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles
Hirofumi Sasaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology
John C. L. Erve
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Bioactivation and hepatotoxicity of nitroaromatic drugs
Urs A. Boelsterli et al.
CURRENT DRUG METABOLISM (2006)
Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria
Stephanie Petrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A practical view of 'druggability'
Thomas H. Keller et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro
Ping Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis
Elena Bogatcheva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
LJV Piddock
CLINICAL MICROBIOLOGY REVIEWS (2006)
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
UH Manjunatha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines
M Protopopova et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Bacterial resistance to antibiotics: Active efflux and reduced uptake
A Kumar et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
A comprehensive listing of bioactivation pathways of organic functional groups
AS Kalgutkar et al.
CURRENT DRUG METABOLISM (2005)
Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance
P Domenech et al.
INFECTION AND IMMUNITY (2005)
Inhibitors of type IINADH:-menaquinone oxidoreductase represent a class of antitubercular drugs
EA Weinstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism -: Novel insights into drug mechanisms of action
HIM Boshoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis
CE Barry et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Nitroheterocyclic drugs with broad spectrum activity
W Raether et al.
PARASITOLOGY RESEARCH (2003)
Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates
RE Lee et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2003)
Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection
P Seiler et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
PJ Brennan
TUBERCULOSIS (2003)
Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis
M Viveiros et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
DNA single strand breaks in peripheral blood lymphocytes induced by three nitroimidazole derivatives
GR Ferreiro et al.
TOXICOLOGY LETTERS (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Demonstration that fbiC is required by Mycobacterium bovis BCG for coenzyme F420 and FO biosynthesis
KP Choi et al.
JOURNAL OF BACTERIOLOGY (2002)
Use of transposon Tn5367 mutagenesis and a nitroimidazopyran-based selection system to demonstrate a requirement for fbiA and fbiB in coenzyme F420 biosynthesis by Mycobacterium bovis BCG
KP Choi et al.
JOURNAL OF BACTERIOLOGY (2001)
Comprehensive identification of conditionally essential genes in mycobacteria
CM Sassetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Intracellular pH regulation by Mycobacterium smegmatis and Mycobacterium bovis BCG
M Rao et al.
MICROBIOLOGY-UK (2001)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
Share Paper
